Patent Assignment
Reel/Frame 068682/0617
Assignment of Assignor's Interest
Recorded: 2024-09-24
Pages: 6
Assignors
THOME, BRIAN M.
Executed: 2017-07-14
PARKHURST-LANG, CHERIE
Executed: 2017-07-21
LEVEILLE, BRANDON W.
Executed: 2017-06-29
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(2)
Lyophilized Factor Ix Formulations
Lyophilized Factor Ix Formulations
Application:
18/894,851 →
Publication:
US 2025/0121042